Assessment of the effectiveness of the peptide inhibitor homologous to the transforming growth factor β cytokine blocking the TGFβRI/TGFβRII receptor complex-pilot study.

"CONFLICT OF INTEREST STATEMENT The authors declare that there are no conflicts of interest regarding the publication of this article."

"Many thanks to: Ina Tesseur1, Kun Zou1,3, Elisabeth Berber1, Hui Zhang1 and Tony Wyss‐Coray1,2 from 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA, 2GRECC, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA and 3Department of Alzheimer's Disease Research, National Center for Geriatrics and Gerontology, Obu, Aichi 474–8522, Japan arch. The authors are particularly grateful to Dr. Hui Zhang, PhD, Research Scientist/Lab Manager, Tony Wyss‐Coray Lab, Stanford University, USA, for sending MFB‐F11 cells to Lodz, Poland, guidance in their culture and instructions in conducting experiments. The study was financed from the Polpharm Scientific Foundation, grant no. 16/XIV/2015, Poland."